Cost-Effectiveness and Budget Impact Analyses of Selective Internal Radiation Therapy versus Atezolizumab Plus Bevacizumab from a German Statutory Health Insurance Perspective
-
Published:2024-06
Issue:
Volume:Volume 16
Page:483-492
-
ISSN:1178-6981
-
Container-title:ClinicoEconomics and Outcomes Research
-
language:en
-
Short-container-title:CEOR
Author:
Schwander BjoernORCID,
Klesper Katharina,
Rossol Siegbert,
Herrmann Ken,
Zoellner York
Publisher
Informa UK Limited